Suppr超能文献

利用住院和门诊资源管理血液透析通路并发症。

Utilization of inpatient and outpatient resources for the management of hemodialysis access complications.

作者信息

Rocco M V, Bleyer A J, Burkart J M

机构信息

Department of Medicine/Nephrology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157-1053, USA.

出版信息

Am J Kidney Dis. 1996 Aug;28(2):250-6. doi: 10.1016/s0272-6386(96)90308-x.

Abstract

Complications of hemodialysis accesses are a major cause of morbidity in chronic hemodialysis patients. Although several investigators have reported on the utilization of inpatient services for hemodialysis access complications, there is a paucity of data regarding the utilization of outpatient services and temporary accesses for these complications. In this retrospective study, we identified all access-related inpatient admissions and outpatient encounters and procedures performed in an incident cohort of hemodialysis patients. Eighty-eight patients were followed for an average of 487.4 +/- 316.9 days, for a total of 119.1 patient-years of risk. The mean age was 57.0 +/- 14.6 years, with 55% females and 65% blacks; 31% of patients had diabetes mellitus as the primary cause of end-stage renal disease. Patients were referred to our nephrology practice a median of 56 days prior to the placement of a hemodialysis access and a median of 76 days prior to the initiation of hemodialysis. At the initiation of hemodialysis, 48 native arteriovenous fistulas and 40 polytetrafluoroethylene grafts were placed. Only 28 patients (31.8%) had a permanent access placed at least 14 days before the start of hemodialysis, resulting in the placement of 93 temporary accesses during the first week of dialysis therapy. Because of access complications, 21 patients had failure of their primary access, requiring the placement of 33 additional permanent accesses, including six native arteriovenous fistulas, 23 polytetrafluoroethylene grafts, and four permacaths, or an average of 0.28 new accesses per patient-year of risk. During the study period, 45 patients (51%) had at least one access complication. To manage these access complications, 25 fistulograms (0.21 per patient-year of risk) were performed and 116 additional temporary accesses (0.97 per patient-year of risk) were placed, including 50 femoral (43.1%), 52 subclavian (44.8%), and 14 internal jugular (12.1%) catheters. A total of 2.43 inpatient days and 1.05 outpatient encounters per year of patient risk were directly attributed to admissions solely for access complications. There is significant utilization of outpatient services, temporary accesses, and fistulograms in the management of hemodialysis access complications. These services should be included whenever a review of hemodialysis access procedures or costs are undertaken.

摘要

血液透析通路并发症是慢性血液透析患者发病的主要原因。尽管有几位研究者报告了住院服务用于治疗血液透析通路并发症的情况,但关于门诊服务的利用以及这些并发症的临时通路,相关数据却很匮乏。在这项回顾性研究中,我们确定了血液透析患者发病队列中所有与通路相关的住院、门诊诊疗及操作。88例患者平均随访487.4±316.9天,总风险患者年数为119.1。平均年龄为57.0±14.6岁,女性占55%,黑人占65%;31%的患者因糖尿病作为终末期肾病的主要病因。患者在进行血液透析通路置入前中位时间为56天,在开始血液透析前中位时间为76天被转诊至我们的肾脏病科。在开始血液透析时,置入了48个自体动静脉内瘘和40个聚四氟乙烯移植物。只有28例患者(31.8%)在血液透析开始前至少14天置入了永久性通路,导致在透析治疗的第一周置入了93个临时通路。由于通路并发症,21例患者的初次通路失败,需要额外置入33个永久性通路,包括6个自体动静脉内瘘、23个聚四氟乙烯移植物和4个带涤纶套中心静脉导管,即平均每患者年风险置入0.28个新通路。在研究期间,45例患者(51%)至少发生了一次通路并发症。为处理这些通路并发症,进行了25次瘘管造影(每患者年风险0.21次),并额外置入了116个临时通路(每患者年风险0.97个),包括50个股静脉导管(43.1%)、52个锁骨下静脉导管(44.8%)和14个颈内静脉导管(12.1%)。每年每患者风险有2.43个住院日和1.05次门诊诊疗直接归因于仅因通路并发症的住院治疗。门诊服务、临时通路和瘘管造影在血液透析通路并发症的管理中使用显著。在对血液透析通路操作或成本进行审查时,应纳入这些服务。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验